No Prescription |
 |
 | ||
|
Epanutin Generic Phenytoin sodium |
|
| ||
No Prescription » Prescription Drugs 7 » Epanutin Generic Phenytoin sodium Product Origin: EU (Turkey) This product is able to be sourced and supplied at excellent prices because of favourable cross border currency conversions. All products are authentic brand names and will include a product information insert in English. Medical Information: Epanutin capsules oral suspension and infatabs all contain the active ingredient phenytoin which is a type of medicine called an anticonvulsant. (NB. Phenytoin is also available without a brand name ie as the generic medicine.) Phenytoin is used to treat epilepsy and works by stabilising electrical activity in the brain. The brain and nerves are made up of many nerve cells that communicate with each other through electrical signals. These signals must be carefully regulated for the brain and nerves to function properly. When abnormally rapid and repetitive electrical signals are released in the brain the brain becomes over-stimulated and normal function is disturbed. This can result in fits or seizures. Phenytoin prevents seizures by preventing the excessive electrical activity in the brain. It is thought to achieve this by preventing sodium from entering nerve cells when they begin to fire rapid and repetitive electrical signals. A build up of sodium in the nerve cells is necessary for the electrical signal to build up and be passed on to other nerve cells. As phenytoin prevents this it helps stabilise the electrical activity in the brain. As phenytoin stabilises electrical nerve activity it can also be used to treat a condition called trigeminal neuralgia in which the facial nerves spontaneously send messages of pain to the brain. Phenytoin prevents the nerve signals being sent inappropriately and relieves the pain of this condition. Phenytoin should only be used as second line therapy for this condition in people who cannot take another medicine called carbamazepine or for people in whom carbamazepine is ineffective. What is it used for?<>Epilepsy. Phenytoin is used to treat generalised tonic-clonic seizures (grand mal epilepsy) and partial seizures. Seizures associated with brain surgery or head injury. Severe pain in the lips gums cheek chin or eye caused by a disorder of the nerves in the face (trigeminal neuralgia). Buy Epanutin Generic Phenytoin sodium and other Prescription Drugs 7 products online at Medstore. 4962
About Epanutin Generic Phenytoin sodium: Product Type: Prescription Drugs 7 Epanutin ( Generic Phenytoin sodium ) Epanutin (Generic Phenytoin sodium) Generic Phenytoin sodium 100mg 100 CAPSULES Generic Phenytoin sodium Epanutin
View more Prescription Drugs 7 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
